(Photo via Abbott)

Abbott Announces FDA Approval Of The Alinity™S System, The Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply

Originally posted on abbott.com

Abbott announced U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System.  This new solution will bring the latest screening technology to U.S. blood and plasma centers. Alinity s is designed to screen blood and plasma more efficiently within a smaller space versus commercially available competitive systems. In a testing specialty that can require extensive hands-on time, the additional automation and flexibility of Alinity s will help blood and plasma centers improve productivity and maintain the highest levels of accuracy.

“Alinity s is a significant leap forward when it comes to speed, automation and efficiency for blood and plasma screening,” said Louis Morrone, vice president, Transfusion Medicine, Abbott. “These elements are important to blood and plasma services of all sizes, supporting Abbott’s overall mission to help people live longer, healthier lives by keeping the global blood and plasma supply safe.”

Alinity s will help transform the blood and plasma screening process in terms of speed, capacity and “walk-away” time (i.e., when lab professionals are free to manage other responsibilities while the instrument processes samples) as a result of a number of new features:

  • Expands capacity to run up to 600 tests per hour.
  • Improves centers’ ability to track all activities and actions associated with the testing and processing of each donation in accordance with regulatory requirements.
  • Increases walk-away time to a minimum of three hours while adding the ability to continuously access to refill/restock when convenient to the technician.
  • Equips laboratory professionals with the ability to continuously load and unload samples and supplies without pausing or stopping the system.
  • Features an intuitive software interface, menu design and sample loading layout, shared with other Alinity instruments, making it easy for lab technicians to learn and use.

“In order to ensure a safe blood and plasma supply, we need access to the most advanced technologies to screen donations,” said Rachel-Louise Beddard, M.D., senior vice president and chief medical officer, QualTex Laboratories. “Alinity s will help us transform the way we conduct screening, so we can do our jobs most efficiently, allowing us to get the life-saving blood and plasma products to people facing their most critical situations.”

Latest News

5 Biggest News Stories of the Week: May 26

As the saying goes, the news never stops — but there’s a lot of it out there, and all of it doesn’t always pertain to our readers. In this weekly news roundup, we’ll cover the top news stories that matter most to our diversity focused audience. 1. More Than 200…

Tips from KeyBank on Improving Mental Health in the Workplace

With May being Mental Health Awareness Month, many companies are looking into how to support employees’ mental health and wellbeing in and out of the workplace.  For KeyBank (ranked No. 18 on the 2022 DiversityInc Top 50 Companies for Diversity list), the company listens to its employees and attempts to understand…

KeyBank Awards a $200,000 Grant for an Online High School Diploma Program

Originally published at 3blmedia.com. KeyBank ranked No. 18 on The DiversityInc Top 50 Companies for Diversity list in 2022.   KeyBank is awarding Matrix Human Services, a Detroit-Based social services organization, $200,000 to expand their well-regarded Online High School Diploma Program. This transformative grant is part of KeyBank’s $40 billion National Community Benefits…